Aptar named one of French magazine Capital’s 2024 Best Employers in France and is ranked 14th in Healthcare and Pharmaceuticals category

April 2, 2024 (press release) –

Aptar has been named one of Capital’s 2024 Best Employers in France and is ranked 14th in the Healthcare and Pharmaceuticals category. This achievement underscores our commitment to fostering an inclusive workplace culture and environment that values talent, promotes growth, and prioritizes employee well-being.

Capital Best Employers Methodology

In order to gain insight into what French employees think of the country’s biggest employers, French magazine Capital has teamed up with Statista, a global specialist in economic data analysis, for the 10th consecutive year to compile its annual Best Employers list.

In 2024, Statista conducted an extensive online survey involving 20,000 employees working for companies with over 500 staff members in France. Respondents were asked for their honest opinions on their employers and direct competitors, with no interference from their HR departments.

The survey includes two main questions: “On a scale of 0 to 10, how likely are you to recommend your employer to an acquaintance or family member?” and “Based on everything you know about the following employers in your industry, would you recommend them to an acquaintance or family member?”. Other criteria such as salaries, benefits, work environment, career opportunities, etc. are also assessed and a score out of 10 is calculated, with a higher weighting given to employees’ opinions about their own company.

Out of more than 2,100 companies surveyed, only the 500 with the highest scores were selected.

Diversity, Equity and Inclusion

In June 2023, Capital published its Diversity Champions list  highlighting French companies that have implemented effective policies to address inequalities and promote inclusion for all. Out of 6,000 companies, Aptar was ranked 96th with a score of 8.18 out of 10.  Aptar Pharma was also ranked 4th out of 162 companies assessed in the Healthcare and Pharmaceuticals category.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.